BEDFORD, Ohio, April 13 /PRNewswire/ -- Bedford Laboratories(TM), a division of Ben Venue Laboratories, Inc., announced the addition of Fluconazole injection 2 mg / mL in PVC flexible containers to its existing Fluconazole injection line. This product is AP rated and is equivalent to Diflucan(R) by Pfizer. Fluconazole injection is an antifungal agent indicated for oropharyngeal and esophageal candidiasis, cryptococcal meningitis, and is also indicated for the prophylaxis of candidiasis.
"In our continuing effort to offer the most comprehensive and cost effective line of injectables in the multisource industry, Bedford Laboratories is pleased to begin offering this product in PVC flexible containers. This product represents Bedford's entry into the I.V. bag market and demonstrates our ongoing commitment to providing a broad based portfolio of products," said David Gaugh, Vice President of Bedford Laboratories.
In addition to the glass vial presentations, Bedford Laboratories will supply Fluconazole injection as a sterile iso-osmotic solution containing 2mg / mL of fluconazole in 0.9% sodium chloride diluent in the following presentations: 200mg / 100mL in single-dose PVC flexible containers packaged in cartons containing 10 bags and 400mg / 200mL in single-dose PVC flexible containers packaged in cartons containing 10 bags.
Prescribing information is available upon request from the Bedford Laboratories' professional services department at 800.521.5169, or from the company's web site, www.bedfordlabs.com.
About Bedford Laboratories
|SOURCE Bedford Laboratories|
Copyright©2009 PR Newswire.
All rights reserved